- HCMS Value Prop
- The Problem
Healthcare Costs are Threatening the Survival of your Business!
Despite decades of attempts to slow them down, healthcare costs continue to grow much faster than inflation. 
- Evidence
♦ In the US we spend 30% more on healthcare, get 30% less (compared with other industrialized nations.)
♦ Healthcare spending is increasing at the expense of wages.
♦ We're over spending on specialty and institutional care, and under-spending on primary care.
- The Solution
Create Your Own Healthcare Reform: Get the Incentives Right.
We can help you do it. Read our blog and learn more about HCMS Group's unique services. Find out why we're different. 
- Our Clients
- Getting Started
Get Your Incentives Alignment Score
A quick way to size up the challenge. How well are your company's incentives aligned with your workers'? Which benefit costs can be modified and which can't?
Measure and Monitor - Data Analytics and O|BI
The intelligence behind what's driving human capital risk in your population
5% "High Risk" Solution
Impact your high-risk and high-need employees with the proven "5% solution" that is used by some of the highest performing companies in America
Who We Are
HCMS Group combines powerful data analytics and a proven, unique clinical prevention service to help businesses reduce their health benefit costs, and also support those employees with the greatest health risks. We identify ways that companies can “get the incentives right” between employers and workers, and in doing so, control runaway health benefit costs that can threaten business survival.
Watch our short video introduction (02:47):
Why We're Different
HCMS Group services are grounded in market economics. We help our clients simultaneously improve business performance, improve human capital performance, and improve the quality while lowering the cost of their benefit plans. Learn more...
Featured Post
HCMS Group Epilepsy Research Published in Research Journal
HCMS Group is proud to announce that their epilepsy research, conducted along with Pfizer, Inc. and neurologists from the Universities of Alabama and Arizona, has been published in the journal Epilepsy Research. The article is titled “Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin.” The research compares the costs, absence…
Continue Reading »Order the Books!
WHO SURVIVES?
HOW BENEFIT COSTS ARE KILLING YOUR COMPANY
by: Wendy Lynch, Ph.D.
and Hank Gardner, M.D.
Videos require Flash Version 10 or higher (not required on iPad/iPhone.) Check version and download Adobe Flash